Leading Pharmaceutical Company Expands to Mexico City

From Business Wire - Eisai, one of the leading global pharmaceutical companies, has announced that the company is establishing a subsidiary company in Mexico City. Eisai's commercial focus is on neurology, gastrointestinal disorders and oncology/critical care.

Eisai President of New Markets and ASEAN, Hajime Shimizu stated, “The establishment of this new company enables Eisai to introduce many of its products to people living in Mexico who currently do not have access to these medicines, and this is essential to Eisai’s human health care (hhc) mission to satisfy unmet medical needs and contribute to the health and well-being of people worldwide.” Read more about this new business to Mexico here.